-
2
-
-
0021734201
-
Protein-energy intake and malnutrition in Crohn's disease
-
Hodges P, Gee M, Grace M, Sherbaniuk RW, Wensel RH, Thomson AB. Protein-energy intake and malnutrition in Crohn's disease. J Am Diet Assoc 1984;84:1460-4.
-
(1984)
J Am Diet Assoc
, vol.84
, pp. 1460-1464
-
-
Hodges, P.1
Gee, M.2
Grace, M.3
Sherbaniuk, R.W.4
Wensel, R.H.5
Thomson, A.B.6
-
3
-
-
0019366725
-
Reversal of growth retardation in Crohn's disease with therapy emphasizing oral nutritional restitution
-
Kirschner BS, Klich JR, Kalman SS, deFavaro MV, Rosenberg IH. Reversal of growth retardation in Crohn's disease with therapy emphasizing oral nutritional restitution. Gastroenterology 1981;80:10-5.
-
(1981)
Gastroenterology
, vol.80
, pp. 10-15
-
-
Kirschner, B.S.1
Klich, J.R.2
Kalman, S.S.3
deFavaro, M.V.4
Rosenberg, I.H.5
-
4
-
-
0028956869
-
Insulin-like growth factor binding proteins
-
Bach LA, Rechler MM. Insulin-like growth factor binding proteins. Diabetes Rev 1995;3:38-61.
-
(1995)
Diabetes Rev
, vol.3
, pp. 38-61
-
-
Bach, L.A.1
Rechler, M.M.2
-
5
-
-
0030876829
-
Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency
-
Juul A, Holm K, Kastrup KW, Pedersen SA, Michaelsen KF, Scheike T, et al. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab 1997;82:2497-502.
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 2497-2502
-
-
Juul, A.1
Holm, K.2
Kastrup, K.W.3
Pedersen, S.A.4
Michaelsen, K.F.5
Scheike, T.6
-
6
-
-
4444284454
-
Free insulin-like growth factors: Measurements and relationships to growth hormone secretion and glucose homeostasis
-
Frystyk J. Free insulin-like growth factors: measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res 2004;14:337-75.
-
(2004)
Growth Horm IGF Res
, vol.14
, pp. 337-375
-
-
Frystyk, J.1
-
7
-
-
0028789723
-
Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor
-
Fan J, Char D, Bagby GJ, Gelato MC, Lang CH. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. Am J Physiol 1995;269:R1204-12.
-
(1995)
Am J Physiol
, vol.269
-
-
Fan, J.1
Char, D.2
Bagby, G.J.3
Gelato, M.C.4
Lang, C.H.5
-
8
-
-
0030512124
-
Proinflammatory cytokines interleukin 1 beta and tumor necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells
-
Wolf M, Bohm S, Brand M, Kreymann G. Proinflammatory cytokines interleukin 1 beta and tumor necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells. Eur J Endocrinol 1996;135:729-37.
-
(1996)
Eur J Endocrinol
, vol.135
, pp. 729-737
-
-
Wolf, M.1
Bohm, S.2
Brand, M.3
Kreymann, G.4
-
9
-
-
18444379959
-
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease
-
Vespasiani GU, Caviglia R, Picardi A, Carotti S, Ribolsi M, Galati G, et al. Infliximab reverses growth hormone resistance associated with inflammatory bowel disease. Aliment Pharmacol Ther 2005;21:1063-71.
-
(2005)
Aliment Pharmacol Ther
, vol.21
, pp. 1063-1071
-
-
Vespasiani, G.U.1
Caviglia, R.2
Picardi, A.3
Carotti, S.4
Ribolsi, M.5
Galati, G.6
-
10
-
-
0030937446
-
Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population based study
-
Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997;40:313-9.
-
(1997)
Gut
, vol.40
, pp. 313-319
-
-
Jahnsen, J.1
Falch, J.A.2
Aadland, E.3
Mowinckel, P.4
-
11
-
-
0034066374
-
Fracture risk is increased in Crohn's disease, but not in ulcerative colitis
-
Vestergaard P, Krogh K, Rejnmark L, Laurberg S, Mosekilde L. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 2000;46:176-81.
-
(2000)
Gut
, vol.46
, pp. 176-181
-
-
Vestergaard, P.1
Krogh, K.2
Rejnmark, L.3
Laurberg, S.4
Mosekilde, L.5
-
12
-
-
33644976247
-
Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease
-
Abreu MT, Geller JL, Vasiliauskas EA, Kam LY, Vora P, Martyak LA, et al. Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease. J Clin Gastroenterol 2006;40:55-63.
-
(2006)
J Clin Gastroenterol
, vol.40
, pp. 55-63
-
-
Abreu, M.T.1
Geller, J.L.2
Vasiliauskas, E.A.3
Kam, L.Y.4
Vora, P.5
Martyak, L.A.6
-
13
-
-
0031049121
-
Reduced bone density in patients with inflammatory bowel disease
-
Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997;40:228-33.
-
(1997)
Gut
, vol.40
, pp. 228-233
-
-
Bjarnason, I.1
Macpherson, A.2
Mackintosh, C.3
Buxton-Thomas, M.4
Forgacs, I.5
Moniz, C.6
-
14
-
-
0017227303
-
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
-
Best WR, Becktel JM, Singleton JW, Kern F, Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
-
(1976)
Gastroenterology
, vol.70
, pp. 439-444
-
-
Best, W.R.1
Becktel, J.M.2
Singleton, J.W.3
Kern Jr., F.4
-
15
-
-
0019319257
-
A simple index of Crohn's-disease activity
-
Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1:514.
-
(1980)
Lancet
, vol.1
, pp. 514
-
-
Harvey, R.F.1
Bradshaw, J.M.2
-
16
-
-
0021813187
-
Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
-
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
-
(1985)
Diabetologia
, vol.28
, pp. 412-419
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
Naylor, B.A.4
Treacher, D.F.5
Turner, R.C.6
-
17
-
-
0029615371
-
Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II
-
Frystyk J, Dinesen B, Ørskov H. Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. Growth Regul 1995;5:169-76.
-
(1995)
Growth Regul
, vol.5
, pp. 169-176
-
-
Frystyk, J.1
Dinesen, B.2
Ørskov, H.3
-
18
-
-
0028362124
-
-
Frystyk J, Skjærbæk C, Dinesen B, Ørskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett 1994;348:185-91.
-
Frystyk J, Skjærbæk C, Dinesen B, Ørskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett 1994;348:185-91.
-
-
-
-
19
-
-
0028598184
-
The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy
-
Westwood M, Gibson JM, Davies AJ, Young RJ, White A. The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab 1994;79:1735-41.
-
(1994)
J Clin Endocrinol Metab
, vol.79
, pp. 1735-1741
-
-
Westwood, M.1
Gibson, J.M.2
Davies, A.J.3
Young, R.J.4
White, A.5
-
20
-
-
0037241331
-
Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease
-
Krassas GE, Pontikides N, Kaltsas T, Dumas A, Frystyk J, Chen JW, et al. Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease. J Clin Endocrinol Metab 2003;88:132-5.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 132-135
-
-
Krassas, G.E.1
Pontikides, N.2
Kaltsas, T.3
Dumas, A.4
Frystyk, J.5
Chen, J.W.6
-
21
-
-
25444482793
-
Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology
-
Skogstrand K, Thorsen P, Nørgaard-Pedersen B, Schendel DE, Sørensen LC, Hougaard DM. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 2005;51:1854-66.
-
(2005)
Clin Chem
, vol.51
, pp. 1854-1866
-
-
Skogstrand, K.1
Thorsen, P.2
Nørgaard-Pedersen, B.3
Schendel, D.E.4
Sørensen, L.C.5
Hougaard, D.M.6
-
22
-
-
18244417601
-
Low free and total insulin-like growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: Partial normalization during prednisolone treatment
-
Grønbæk H, Thøgersen T, Frystyk J, Vilstrup H, Flyvbjerg A, Dahlerup JF. Low free and total insulin-like growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment. Am J Gastroenterol 2002;97:673-8.
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 673-678
-
-
Grønbæk, H.1
Thøgersen, T.2
Frystyk, J.3
Vilstrup, H.4
Flyvbjerg, A.5
Dahlerup, J.F.6
-
23
-
-
0027225655
-
Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease
-
Thomas AG, Holly JM, Taylor F, Miller V. Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease. Gut 1993;34:944-7.
-
(1993)
Gut
, vol.34
, pp. 944-947
-
-
Thomas, A.G.1
Holly, J.M.2
Taylor, F.3
Miller, V.4
-
24
-
-
27144527515
-
Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroids
-
Eivindson M, Grønbæk H, Nielsen JN, Frystyk J, Flyvbjerg A, Jørgensen L, et al. Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroids. Scand J Gastroenterol 2005;40:1214-21.
-
(2005)
Scand J Gastroenterol
, vol.40
, pp. 1214-1221
-
-
Eivindson, M.1
Grønbæk, H.2
Nielsen, J.N.3
Frystyk, J.4
Flyvbjerg, A.5
Jørgensen, L.6
-
25
-
-
0038637213
-
The effect of growth hormone on the insulin-like growth factor system during fasting
-
Nørrelund H, Frystyk J, Jørgensen JO, Møller N, Christiansen JS, Ørskov H, et al. The effect of growth hormone on the insulin-like growth factor system during fasting. J Clin Endocrinol Metab 2003;88:3292-8.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 3292-3298
-
-
Nørrelund, H.1
Frystyk, J.2
Jørgensen, J.O.3
Møller, N.4
Christiansen, J.S.5
Ørskov, H.6
-
27
-
-
0029744227
-
Nutritional regulation of IGF-I and IGFBPs
-
Underwood LE. Nutritional regulation of IGF-I and IGFBPs. J Pediatr Endocrinol Metab 1996;9 Suppl 3:303-12.
-
(1996)
J Pediatr Endocrinol Metab
, vol.9
, Issue.SUPPL. 3
, pp. 303-312
-
-
Underwood, L.E.1
-
28
-
-
16644365098
-
Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease
-
Bannerjee K, Camacho-Hübner C, Babinska K, Dryhurst KM, Edwards R, Savage MO, et al. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 2004;38:270-5.
-
(2004)
J Pediatr Gastroenterol Nutr
, vol.38
, pp. 270-275
-
-
Bannerjee, K.1
Camacho-Hübner, C.2
Babinska, K.3
Dryhurst, K.M.4
Edwards, R.5
Savage, M.O.6
-
29
-
-
33847337508
-
The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's Disease: Relations to disease activity and corticosteroid treatment
-
in press
-
Eivindson M, Grønbæk H, Flyvbjerg A, Frystyk J, Zimmermann-Nielsen E, Dahlerup JF. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's Disease: relations to disease activity and corticosteroid treatment. Growth Horm IGF Res 2006; in press.
-
(2006)
Growth Horm IGF Res
-
-
Eivindson, M.1
Grønbæk, H.2
Flyvbjerg, A.3
Frystyk, J.4
Zimmermann-Nielsen, E.5
Dahlerup, J.F.6
-
30
-
-
9244236538
-
Insulin-like growth factor I: The yin and yang of muscle atrophy
-
Heszele MF, Price SR. Insulin-like growth factor I: the yin and yang of muscle atrophy. Endocrinology 2004;145:4803-5.
-
(2004)
Endocrinology
, vol.145
, pp. 4803-4805
-
-
Heszele, M.F.1
Price, S.R.2
-
31
-
-
4544305960
-
Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease
-
Borrelli O, Bascietto C, Viola F, Bueno DM, Barbato M, Mancini V, et al. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Dig Liver Dis 2004;36:342-7.
-
(2004)
Dig Liver Dis
, vol.36
, pp. 342-347
-
-
Borrelli, O.1
Bascietto, C.2
Viola, F.3
Bueno, D.M.4
Barbato, M.5
Mancini, V.6
-
32
-
-
22244433242
-
Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor a treatment
-
Briot K, Garnero P, Le Henanff A, Dougados M, Roux C. Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor a treatment. Ann Rheum Dis 2005;64:1137-40.
-
(2005)
Ann Rheum Dis
, vol.64
, pp. 1137-1140
-
-
Briot, K.1
Garnero, P.2
Le Henanff, A.3
Dougados, M.4
Roux, C.5
-
33
-
-
0032132830
-
Expression of insulin-like growth factor binding proteins in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis
-
Allen JT, Bloor CA, Knight RA, Spiteri MA. Expression of insulin-like growth factor binding proteins in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. Am J Respir Cell Mol Biol 1998;19:250-8.
-
(1998)
Am J Respir Cell Mol Biol
, vol.19
, pp. 250-258
-
-
Allen, J.T.1
Bloor, C.A.2
Knight, R.A.3
Spiteri, M.A.4
-
34
-
-
0037530073
-
The insulin-like growth factor axis in children with inflammatory bowel disease
-
Corkins MR, Gohil AD, Fitzgerald JF. The insulin-like growth factor axis in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2003;36:228-34.
-
(2003)
J Pediatr Gastroenterol Nutr
, vol.36
, pp. 228-234
-
-
Corkins, M.R.1
Gohil, A.D.2
Fitzgerald, J.F.3
-
35
-
-
0027413596
-
Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients
-
Cohen P, Peehl DM, Stamey TA, Wilson KF, Clemmons DR, Rosenfeld RG. Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab 1993;76:1031-5.
-
(1993)
J Clin Endocrinol Metab
, vol.76
, pp. 1031-1035
-
-
Cohen, P.1
Peehl, D.M.2
Stamey, T.A.3
Wilson, K.F.4
Clemmons, D.R.5
Rosenfeld, R.G.6
-
36
-
-
0035145813
-
The insulin-like growth factor system in human immunodeficiency virus infection: Relations to immunological parameters, disease progression, and antiretroviral therapy
-
Helle SI, Ueland T, Ekse D, Frøland SS, Holly JM, Lønning PE, et al. The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapy. J Clin Endocrinol Metab 2001;86:227-33.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 227-233
-
-
Helle, S.I.1
Ueland, T.2
Ekse, D.3
Frøland, S.S.4
Holly, J.M.5
Lønning, P.E.6
-
37
-
-
0028828311
-
Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis
-
Kratzsch J, Blum WF, Schenker E, Keller E. Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis. Exp Clin Endocrinol Diabetes 1995;103:285-91.
-
(1995)
Exp Clin Endocrinol Diabetes
, vol.103
, pp. 285-291
-
-
Kratzsch, J.1
Blum, W.F.2
Schenker, E.3
Keller, E.4
-
38
-
-
0037018761
-
Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial
-
Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002;359:1541-9.
-
(2002)
Lancet
, vol.359
, pp. 1541-1549
-
-
Hanauer, S.B.1
Feagan, B.G.2
Lichtenstein, G.R.3
Mayer, L.F.4
Schreiber, S.5
Colombel, J.F.6
-
39
-
-
0028511246
-
Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): A review
-
Brynskov J, Nielsen OH, Ahnfelt-Rønne I, Bendtzen K. Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review. Dig Dis 1994;12:290-304.
-
(1994)
Dig Dis
, vol.12
, pp. 290-304
-
-
Brynskov, J.1
Nielsen, O.H.2
Ahnfelt-Rønne, I.3
Bendtzen, K.4
-
40
-
-
0029050742
-
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
-
van Dullemen HM, Van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129-35.
-
(1995)
Gastroenterology
, vol.109
, pp. 129-135
-
-
van Dullemen, H.M.1
Van Deventer, S.J.2
Hommes, D.W.3
Bijl, H.A.4
Jansen, J.5
Tytgat, G.N.6
-
41
-
-
0033179725
-
Clinical relevance of serum interleukin-6 in Crohn's disease: Single point measurements, therapy monitoring, and prediction of clinical relapse
-
Reinisch W, Gasche C, Tillinger W, Wyatt J, Lichtenberger C, Willheim M, et al. Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse. Am J Gastroenterol 1999;94:2156-64.
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 2156-2164
-
-
Reinisch, W.1
Gasche, C.2
Tillinger, W.3
Wyatt, J.4
Lichtenberger, C.5
Willheim, M.6
-
42
-
-
17744373658
-
Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease
-
Cornillie F, Shealy D, D'Haens G, Geboes K, Van Assche G, Ceuppens J, et al. Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease. Aliment Pharmacol Ther 2001;15:463-73.
-
(2001)
Aliment Pharmacol Ther
, vol.15
, pp. 463-473
-
-
Cornillie, F.1
Shealy, D.2
D'Haens, G.3
Geboes, K.4
Van Assche, G.5
Ceuppens, J.6
-
43
-
-
0031573593
-
A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease
-
Plevy SE, Landers CJ, Prehn J, Carramanzana NM, Deem RL, Shealy D, et al. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 1997;159:6276-82.
-
(1997)
J Immunol
, vol.159
, pp. 6276-6282
-
-
Plevy, S.E.1
Landers, C.J.2
Prehn, J.3
Carramanzana, N.M.4
Deem, R.L.5
Shealy, D.6
-
44
-
-
0022517548
-
Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease
-
Kirschner BS, Sutton MM. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 1986;91:830-6.
-
(1986)
Gastroenterology
, vol.91
, pp. 830-836
-
-
Kirschner, B.S.1
Sutton, M.M.2
-
45
-
-
0031716730
-
Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease
-
Beattie RM, Camacho-Hübner C, Wacharasindhu S, Cotterill AM, Walker-Smith JA, Savage MO. Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease. Clin Endocrinol (Oxf) 1998;49:483-9.
-
(1998)
Clin Endocrinol (Oxf)
, vol.49
, pp. 483-489
-
-
Beattie, R.M.1
Camacho-Hübner, C.2
Wacharasindhu, S.3
Cotterill, A.M.4
Walker-Smith, J.A.5
Savage, M.O.6
|